BIA’s Science and Innovation Advisory Committee (SIAC) are delivering a series of webinars in 2019 entitled ‘Bench to Bedside’.
This webinar, presented by Dr Penny Ward, will discuss the types of biomarker used in preclinical and clinical development and considers the factors leading to biomarker qualification as well as steps which may lead to approval of the marker as a surrogate endpoint for drug approval.
The content has been proposed by industry and will explore the drug discovery process from discovery to delivery. The series will be concluded with a panel session at our UK Bioscience Forum on 17 October.
Visit our website for more information: www.bioindustry.org/event-listing.html
